Steven L. Stice
Gründer bei Aruna Bio, Inc.
Profil
Steven L.
Stice is the founder of Aruna Bio, Inc., a company founded in 2003, where he currently holds the title of Director & Chief Scientific Officer.
He also held the position of Director-Regenerative Bioscience Center at the University of Georgia.
Additionally, he worked as a Consultant at BresaGen, Inc. and as Chief Executive & Scientific Officer at Astellas Institute for Regenerative Medicine.
Aktive Positionen von Steven L. Stice
Unternehmen | Position | Beginn |
---|---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Gründer | 13.01.2010 |
Ehemalige bekannte Positionen von Steven L. Stice
Unternehmen | Position | Ende |
---|---|---|
University of Georgia | Corporate Officer/Principal | 04.07.2011 |
OCATA THERAPEUTICS INC | Vorstandsvorsitzender | - |
BresaGen, Inc. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Aruna Bio, Inc.
Aruna Bio, Inc. Medical/Nursing ServicesHealth Services Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA. | Health Services |
BresaGen, Inc. | Commercial Services |
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |